Featured Research

The Medical Cannabis Weekly Review & Newsletter: Hydrogen Cyanide in Vapes, Flavonoids Shrinking Tumors, Rising Healthcare Costs, and more

Written by Alexandra Hicks
Current Deals

The vaping discoveries keep getting more and more disturbing, with the newest research pointing towards hydrogen cyanide as the possible culprit in these hospitalizations.

Also, a more positive new study indicates that flavonoids can shrink deadly pancreatic tumors. Plus, Australia is launching the first-ever human study of using cannabinoids to treat the difficult to manage symptoms of dementia. All that and more in this week’s Medical Cannabis Weekly Review & Newsletter. 


FEATURED STORY: Vapes Tainted with Hydrogen Cyanide – Death Toll Up To 20

hydrogen cyanide

As of October 8, 2019, there are 805 cases of acute onset vaping-related lung injury throughout 46 states and the U.S. Virgin Islands. The full death toll is up to 20 now – two in California, Kansas, and Oregon, and one in each of the following states: Alabama, Delaware, Illinois, Indiana, Massachusetts, Minnesota, Missouri, Florida, Georgia, Mississippi and Nebraska, New Jersey and Virginia. There is also 1 confirmed death in the U.K.

Seeking answers, NBC News commissioned a study in which they recruited one of the most prominent cannabis testing labs in the nation, CannaSafe, to check 18 samples obtained from both legal dispensaries and black market dealers. They were shocked by what they found. 

Click here to read the full story

Subscribe to the Medical Cannabis Weekly Newsletter

Must Read Articles:

New Study Suggests Cannabis Flavonoids Could Shrink Pancreatic Tumors

cannabis pancreatic cancer

Pancreatic cancer is one of the deadliest forms of cancer in humans. But a recent Harvard study on mice has demonstrated that flavonoids in cannabis could shrink pancreatic cancer tumors. In the study, 70% of the mice treated with the compound saw tumors reduced to almost nothing or disappearing altogether. 

Click here to read the full story

Subscribe to the Medical Cannabis Weekly Newsletter

First-Ever Human Trial For Cannabis and Dementia Begins Now

dementia cannabis

After nearly two years of meticulous planning, The Institute for Health Research at University of Notre Dame (UNDA) in Western Australia is officially starting the clinical trials to discover the impact of cannabis on the various symptoms of dementia. 

Click here to read the full story 

Subscribe to the Medical Cannabis Weekly Newsletter

What We Can All Do About Rising Healthcare Costs

Rising healthcare costs are spiraling out of control.

Healthcare costs are spiraling out of control. In 2018 alone, U.S. health care costs equaled over $3.6 trillion. That’s trillion with a T. That means the burden of covering costly care falls to Americans, many of which are struggling enough to make ends meet.

Click here to read the full story 

Subscribe to the Medical Cannabis Weekly Newsletter

Other Trending News:

User Review
0 (0 votes)

About the author

Alexandra Hicks

Alexandra is the managing editor at CBD Testers. She has always been interested in alternative and natural remedies, and the versatility of cannabis as a healing plant is something that greatly appeals to her. It's for this reason that she decided to work as a cannabis industry journalist and editor, to help spread accurate information about the benefits of this plant.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: